Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Revolution Medicines

Tracked across 2 events · 195 articles · First seen Apr 15, 2026 · Last active Jul 05, 2026

Sentiment
15
Attention
7
Events
2
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
7 10
Regulatory
Impact: Revolution Medicines is the company that accused Erasca of patent infringement and trade secret misappropriation related to Erasca's ERAS-0015, claiming improper comparisons to its own drug candidate RMC-6236. This action has negatively impacted Erasca.
May 19, 2026 · 189 articles
4 20
Regulatory
Impact: Revolution Medicines (RevMed) is the company that alleged Erasca's ERAS-0015 infringes on its patent and involves trade secret misappropriation, initiating the legal dispute.
Jun 11, 2026 · 6 articles
Erasca competitor Revolution Medicines Revolution Medicines is a precision oncology company competing directly against
Erasca competitor Revolution Medicines Erasca is a clinical-stage oncology company that directly competes with Revoluti
ERGEN INTELLIGENCE
Track Revolution Medicines live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.